RegulyzeTamatar
Solanum lycopersicum · Fruit powder/extract
Tamatar (Solanum lycopersicum) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | As specified / GMP | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Tamatar
Tamatar is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Solanum lycopersicum). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Tamatar permitted in nutraceuticals under FSSAI (India)?
Tamatar (Solanum lycopersicum) (listed in the regulation as “Solanum lycopersicum fruit powder/extract”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Tamatar?
No single numeric limit is listed in the source for Tamatar; permitted use is at GMP or as specified. Confirm against the current regulation.
What product category does Tamatar belong to?
Tamatar is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Tamatar?
Tamatar corresponds to Solanum lycopersicum, with the fruit powder/extract used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.